Please assess the completion status of the following clinical trial:

Trial Title: Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* pregnant patients with a previous history of preeclampsia in the immediate preceding pregnancy.~* 18 to 45 years of age will be included.~Exclusion Criteria:~* Patients with chronic hypertension~* children (age \< 17 years)~* Patients that are currently taking anti-psychotics or Selective Serotonin Re-uptake Inhibitors~* patients on medications which may be detrimental to the study interpretation will also be excluded at the principal investigator's discretion.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Aspirin plus Placebo Oral Tablet (Type: PLACEBO_COMPARATOR): Drug: Aspirin 81 mg, given orally once per day Drug: Placebo tablet given orally, once a day
- Aspirin plus Progesterone (Type: ACTIVE_COMPARATOR): Drug: Aspirin 81mg, given orally once per day Drug: Progesterone 200mg given orally, once a day

Based on this trial design, predict the completion outcome and termination type (if applicable).